- Home
- KFS vs RNAC Comparison
KFS vs RNAC Comparison
Compare KFS & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFS
- RNAC
- Stock Information
- Founded
- KFS 1989
- RNAC 2007
- Country
- KFS United States
- RNAC United States
- Employees
- KFS N/A
- RNAC N/A
- Industry
- KFS Property-Casualty Insurers
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- KFS Finance
- RNAC Health Care
- Exchange
- KFS Nasdaq
- RNAC Nasdaq
- Market Cap
- KFS 338.1M
- RNAC 282.6M
- IPO Year
- KFS 1996
- RNAC 2016
- Fundamental
- Price
- KFS $14.83
- RNAC $13.32
- Analyst Decision
- KFS
- RNAC Strong Buy
- Analyst Count
- KFS 0
- RNAC 5
- Target Price
- KFS N/A
- RNAC $40.00
- AVG Volume (30 Days)
- KFS 120.6K
- RNAC 79.0K
- Earning Date
- KFS 08-05-2025
- RNAC 08-07-2025
- Dividend Yield
- KFS N/A
- RNAC N/A
- EPS Growth
- KFS N/A
- RNAC N/A
- EPS
- KFS N/A
- RNAC N/A
- Revenue
- KFS $114,710,000.00
- RNAC $34,173,000.00
- Revenue This Year
- KFS N/A
- RNAC N/A
- Revenue Next Year
- KFS N/A
- RNAC N/A
- P/E Ratio
- KFS N/A
- RNAC N/A
- Revenue Growth
- KFS 6.75
- RNAC 31.91
- 52 Week Low
- KFS $7.06
- RNAC $8.46
- 52 Week High
- KFS $16.80
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- KFS 57.54
- RNAC 65.93
- Support Level
- KFS $14.73
- RNAC $10.71
- Resistance Level
- KFS $16.80
- RNAC $15.57
- Average True Range (ATR)
- KFS 0.90
- RNAC 1.02
- MACD
- KFS -0.04
- RNAC 0.34
- Stochastic Oscillator
- KFS 49.00
- RNAC 63.74
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.